Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 2, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 5, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-092207
Filed / recorded
Mar 5, 2026, 1:54 AM UTC
Added to OQRO
Oct 6, 2026, 9:10 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Sotera Health Co
Issuer CIK
1822479
Ticker
SHC
Reporting person
Jonathan M. Lyons
Relationship
Officer
Officer title
Sr. Vice President, CFO
Security
Performance RSUs
Table
Derivative (Table II)
Transaction date
Mar 2, 2026
Transaction code
A
Shares / units
29,678
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
29,678
Ownership form
Direct
Amendment
No
Footnotes from the filing
These securites consist of the maximum number of additional performance-based RSUs that were granted on March 2, 2026, prusuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related conditions. The additional RSUs generally vest annually in 60%, 20% and 20% installments, respectfully, commencing March 2027, subject to performance.